AstraZeneca

Open: 65.33 Close: 64.85 Change: -0.48

The 9 top things that an AI found about AstraZeneca... they will surprise you

How much time have you spent trying to decide whether investing in AstraZeneca? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AstraZeneca are: AstraZeneca, share, …

Concept Map

Semantic Network

Stock Summary

AstraZeneca PLC focuses on the discovery, development, manufacture, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa,.

Today's Summary

European stock markets mostly in the green despite eurozone data suggesting a decline in manufacturing activity in June. European Stocks Rise, AstraZeneca drops after lung-Cancer trial update.

Today's News

European Stocks Rise, AstraZeneca Drops After Lung-Cancer Trial Update. Data for overall survival was not mature and pointed toward to the results being not statistically significant. AstraZeneca PLC (AZN) closed at $64.85 in the latest trading session, marking a -0.86% move from the prior day. New-York listed ADR rose 2.6% shortly after the open; shares in the drugmaker sold off Monday. AstraZeneca said an experimental precision drug slowed progression of lung cancer in a late-stage trial, but the companys shares fell as much as 6% as analysts said the benefits may not be as pronounced as hoped. The drug, datopotamab deruxtecan, which is being jointly developed with Japans. AstraZeneca and Daiichi Sankyo reported mixed results Monday from a final-phase study of their lung cancer treatment. European stock markets mostly in the green despite eurozone data suggesting a decline in manufacturing activity in June. AstraZeneca shares dropped around 6% in early Monday trading. Company paid $85 million upfront to Quell Therapeutics to develop Treg therapies for Type 1 diabetes and inflammatory bowel disorder. Astrazeneca plc has fallen 1.41% over the past month, closing at $73.20 on June 5. The company added an indication to Lynparzas label for the treatment of adults with metastatic castration-resistant prostate cancer. Astrazeneca shares slipped 2.75% to £103.28 Thursday, on what proved to be an all-around poor trading session for the stock market. FTSE 100 Index UKX fell 2.17% to 7,280.50. AstraZeneca PLC closed £20.64 below its 52-week high (£123.92) AstraZeneca has expanded its global reforestation program with an enhanced commitment to plant over 200 million trees worldwide by the end of the decade. The commitment is backed by $400 million of fresh investment. Astra Zeneca said it would work with planting experts, local communities and governments. AstraZeneca Information Center in the U.S. is available for general or product questions. Healthcare professionals may also visit our HCP Medical Information page.

Stock Profile

"AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Andexxa/Ondexxya, Atacand, Atacand HCT, Atacand Plus, Brilinta/Brilique, Bydureon/Byetta, BCise, Byetta, Crestor, Evrenzo, Farxiga/Forxiga, Komboglyze/Kombiglyze XR, Lokelma, Onglyza, Qtern, Xigduo/Xigduo, and Zestril XR for cardiovascular, renal, and metabolism diseases; Accolate, Accoleit, Vanticon, Bevespi Aerosphere, Breztri Aerosphere, Bricanyl Respules and Turbuhaler, Daliresp/Daxas, Duaklir Genuair, Fasenra, Pulmicort, Rhinocort, Saphnelo, Symbicort, and Tezspire for respiratory and immunology; and Kanuma, Soliris, Strensiq, and Ultomiris for rare diseases. Its marketed products also comprise Synagis for respiratory syncytial virus; Fluenz Tetra/FluMist Quadrivalent for Influenza; and Vaxzevria and Evusheld for covid-19. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006; and Personalis, Inc. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom."

Keywords

This document will help you to evaluate AstraZeneca without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AstraZeneca are: AstraZeneca, share, trading, Monday, say, cancer, European, and the most common words in the summary are: astrazeneca, stock, news, market, top, option, best, . One of the sentences in the summary was: European stock markets mostly in the green despite eurozone data suggesting a decline in manufacturing activity in June. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #astrazeneca #stock #news #market #top #option #best.